KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,151,000 | +858.1% | 82,038 | +861.8% | 0.00% | – |
| Q2 2015 | $642,000 | +75.9% | 8,530 | -19.0% | 0.00% | – |
| Q4 2014 | $365,000 | -54.7% | 10,530 | -57.1% | 0.00% | – |
| Q3 2014 | $805,000 | -42.4% | 24,566 | -32.5% | 0.00% | -100.0% |
| Q2 2014 | $1,397,000 | +7.1% | 36,413 | +11.0% | 0.00% | 0.0% |
| Q1 2014 | $1,304,000 | -79.2% | 32,796 | -80.5% | 0.00% | -75.0% |
| Q4 2013 | $6,276,000 | +433.7% | 168,524 | +554.8% | 0.00% | +300.0% |
| Q3 2013 | $1,176,000 | +6817.6% | 25,738 | +3946.9% | 0.00% | – |
| Q2 2013 | $17,000 | – | 636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |